Fast promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3

European Journal of Immunology

Volumn 29, Issue 11, 1999, Pages 3456-3465

  Xiao, Sheng ^a   Matsui, Ken ^a   Fine, Alan ^a   Zhu, Bangmin ^a   Marshak Rothstein, Ann ^a   Widom, Russel L ^a   Ju, Shyr Te ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Fas ligand; IL 2 signal; NFAT; SP1

Indexed keywords

DNA; FAS LIGAND; INTERLEUKIN 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; CELL EXTRACT; DNA BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 2; EARLY GROWTH RESPONSE FACTOR 3; EGR2 PROTEIN, MOUSE; EGR3 PROTEIN, MOUSE; FASL PROTEIN, MOUSE; MEMBRANE PROTEIN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DNA TRANSFECTION; GENE ACTIVATION; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; ANIMAL; BAGG ALBINO MOUSE; BINDING SITE; CELL NUCLEUS; DRUG EFFECT; GENE DELETION; GENETIC TRANSFECTION; GENETICS; LYMPHOCYTE ACTIVATION; METABOLISM; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE; TRANSACTIVATION;

ANIMALS; BINDING SITES; CELL EXTRACTS; CELL NUCLEUS; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 2; EARLY GROWTH RESPONSE PROTEIN 3; FAS LIGAND PROTEIN; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MUTAGENESIS, SITE-DIRECTED; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); SEQUENCE DELETION; SP1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0032589683     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199911)29:11<3456::AID-IMMU3456>3.0.CO;2-B     Document Type: Article

References (30)

1. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994. 76: 969-976.
2. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M. and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1/Fas. Nature 1995. 373: 438-441.
3. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F. and Green, D. R., Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995. 373: 411-444.
4. Ju, S.-T., Panka, D. J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak-Rothstein, A., Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995. 373: 444-448.
5. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F. and Lynch, D. H., Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995. 181: 71-77.
6. Ju, S.-T., Cui, H., Panka, D. J., Ettinger, R. and Marshak-Rothstein, A., Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. Proc. Natl. Acad. Sci. USA 1994. 91:4185-4189.
7. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 1993. 177: 195-200.
8. Rothstein, T. L., Wang, J. K. L., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S.-T. and Marshak-Rothstein, A., Protection against Fas-dependent Th 1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995. 374: 163-165.
9. Ozdemirli, M., El-Khatib, M., Foote, L. C., Wang, J. K. L., Marshak-Rothstein, A., Rothstein, T. L. and Ju, S.-T., Fas (CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferative responses. Eur. J. Immunol. 1996. 26: 415-419.
10. McNally, J., Yoo, D. H., Drappa, J., Chu, J. L., Yagita, H., Friedman, S. M. and Elkon, K. B., Fas ligand expression and function in systemic lupus erythematosus. J. Immunol. 1997. 159: 4628-4636.
11. Russell, J. H., Rush, B., Weaver, C. and Wang, R., Mature T cells of autoimune Ipr/Ipr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 1993. 90: 4409-4413.
12. Russell, J. H. and Wang, R., Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur. J. Immunol. 1993. 23: 2379-2382.
13. Nakajima, H. and Leonard, W. J., Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice. J. Immunol. 1997. 159: 4737-4744.
14. Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A. and Alt, F. W., Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995. 3: 521-530.
15. Zheng, L., Trageser, C. L., Willerford, D. M. and Lenardo, M. J., T cell growth cytokines cause the super-induction of molecules mediating antigen-induced T lymphocyte death. J. Immunol. 1995. 160: 76-769.
16. Esser, M. T., Dinglasan, R. D., Krishnamurthy, B., Gullo, C. A., Graham, M. B. and Braciale, V. L., IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones. J. Immunol. 1997. 158: 5612-5618.
17. Latinis, K. M., Carr, L. L., Peterson, E. J., Norian, L. A., Eliason, S. L. and Koretzky, G. A., Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 1997. 158: 4602-4611.
18. Holtz-Heppelmann, C. J., Algeciras, A., Badley, A. D. and Paya, C. V., Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 1998. 273: 4416-4423.
19. Matsui, K., Fine, A., Zhu, B., Marshak-Rothstein, A. and Ju, S.-T., Identification of two NF-κB sites in mouse CD95 ligand (Fas Ligand) promoter: Functional analysis in T cell hybridoma. J. Immunol. 1998. 161: 3469-3473.
20. Mittelstadt, P. R. and Ashwell, J. D., Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas Ligand expression. Mol. Cell. Biol. 1998. 18: 3744-3751.
21. Mittelstadt, P. R. and Ashwell, J. D., Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells. J. Biol. Chem. 1999. 274: 3222-3227.
22. Li-Weber, M., Laue, O., Kekele, A., Coy, J., Walczak, H. and Krammer, P. H., A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. Eur. J. Immunol. 1998. 2373-2283.
23. Courey, A. J. and Tjian. R., Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 1988. 55: 887-898.
24. Dao, T., Ohashi, K., Kayano, T., Kurimoto, M. and Okamura, H., Interferon-γ-inducing factor, a novel cytokine, enhances Fas Ligand-mediated cytotoxicity of murine T helper 1 cells. Cell. Immunol. 173: 230-235.
25. Agarwal, S. and Rao, A., Long-range transcriptional regulation of cytokine gene expression. Curr. Opinion. Immunol. 1998. 10: 345-352.
26. Rusterholz, C., Henrioud, P. C. and Nabholz, M., lnterleukin-2 (IL-2) regulates the accessibility of the IL-2-responsive enhancer in the IL-2 receptor a gene to transcription factors. Mol. Cell. Biol. 1999. 19: 2681-2689.
27. Ju, S.-T., Ruddle, N. H., Strack, P., Dorf, M. E. and DeKryuff, R. H., Expression of two distinct cytolytic mechanisms among murine CD4 subsets. J. Immunol. 1990. 144: 23-31.
28. Cui, H., Matsui, K. and Omura, S., Schauer, S. L., Matulka, R. A. Sonenshein, G. E. and Ju, S.-T., Proteasome regulation of activation-induced T cell death. Proc. Natl. Acad. Sci. USA 1997. 94: 7515-7520.
29. Matsui, K., Omura, S., Cui, H., Schauer, S. L., Sonenshein, G. E. and Ju, S.-T., Proteasome regulation of Fas ligand cytotoxicity. Eur. J. Immunol. 1997. 27: 2269-2278.
30. Towbin, H., Staehelin, T. and Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979. 76: 4350-4354.